ACRV1

ACRV1 (SP-10) encodes a hydrophilic peripheral acrosomal protein that functions in sperm-egg interaction during fertilization. The protein is synthesized as a ~45 kDa precursor in round spermatids, undergoes stage-specific endoproteolytic processing by acrosin-like and other intra-acrosomal proteases during spermiogenesis and epididymal transit to yield heterogeneous 18–32 kDa peptides, and localizes to the inner acrosomal membrane and equatorial segment where it persists after the acrosome reaction to mediate sperm-oolemma binding in a β1-integrin-independent manner (PMID:2310816, PMID:1637938, PMID:7888499, PMID:10775167). Spermatid-specific expression is directed by a TATA-less proximal promoter containing an initiator element, whose activity in somatic cells is silenced by a TDP-43-dependent insulator that tethers the promoter to the nuclear matrix and induces RNA polymerase II pausing; in round spermatids this repression is relieved, and NF45/NF90 activates transcription through a Pu-box element (PMID:10529272, PMID:17932037, PMID:21252238, PMID:17942973). In ovarian cancer cells, ectopic ACRV1 transcription is driven by a ZNF280A–CUX2 axis and activates PI3K/AKT signaling and aerobic glycolysis (PMID:41338461).

1. 1990 High

   Determining where SP-10 resides in the sperm head established that it is an intra-acrosomal protein retained on the inner acrosomal membrane and equatorial segment after the acrosome reaction, placing it at the interface of sperm-egg interaction.

   Evidence Light and electron microscopic immunocytochemistry with MHS-10 monoclonal antibody on human sperm before and after ionophore-induced acrosome reaction

   PMID:2310816

   Open questions at the time

   • Functional role in fertilization was inferred but not directly tested
   • No information on how SP-10 remains anchored to the inner acrosomal membrane
2. 1992 High

   Establishing SP-10 as a hydrophilic peripheral protein (not integral membrane) that is endoproteolytically processed at specific sites resolved the molecular basis for its heterogeneous electrophoretic profile and defined the nature of its membrane association.

   Evidence Triton X-114 phase partitioning, chaotropic extraction, affinity chromatography, Edman degradation microsequencing of purified peptides

   PMID:1591355 PMID:1637938

   Open questions at the time

   • Identity of the proteases responsible for each cleavage event was not confirmed beyond inference of acrosin
   • Mechanism of TX-114-resistant anchoring at the equatorial segment remained undefined
3. 1994 High

   Systematic stage-wise analysis showed that SP-10 processing is temporally ordered — a 45 kDa precursor is cleaved in testis, further processed during early epididymal transit, and remains stable thereafter — defining the developmental window of proteolytic maturation.

   Evidence Western blot of human testis, epididymal, ejaculated, and capacitated sperm; EM immunocytochemistry after follicular fluid-induced acrosome reaction

   PMID:7888499

   Open questions at the time

   • Whether processing is required for SP-10 function was not tested
   • Specific proteases active in the epididymis versus testis were not identified
4. 1996 Medium

   Antibody inhibition of bovine IVF demonstrated a functional requirement for SP-10 in sperm-zona secondary binding and acrosome reaction completion, providing the first direct evidence that SP-10 participates in fertilization.

   Evidence Bovine in vitro fertilization assay with anti-SP-10 monoclonal and polyclonal antibodies

   PMID:8882296

   Open questions at the time

   • Cross-species antibody approach leaves species-specific mechanism uncertain
   • Antibody effects on motility complicate interpretation of binding-specific phenotype
5. 1999 High

   Transgenic promoter-deletion analysis identified a ~294 bp proximal region sufficient for spermatid-specific expression from a TATA-less, Inr-dependent promoter, defining the cis-regulatory architecture controlling ACRV1 transcription during acrosome biogenesis.

   Evidence Transgenic mice carrying GFP reporter driven by serial SP-10 5′ flanking deletions; RT-PCR

   PMID:10529272

   Open questions at the time

   • Trans-acting factors driving spermatid specificity were not identified at this stage
   • Chromatin state at the endogenous locus was not characterized
6. 2000 Medium

   Functional dissection distinguished SP-10's role: it mediates sperm-oolemma binding (not zona binding) in a β1-integrin-independent manner, narrowing its function to the post-acrosome-reaction fusion step.

   Evidence Zona-free hamster egg penetration test, hemizona assay, F9 cell binding assay lacking β1-integrin; anti-SP-10 antibody inhibition

   PMID:10775167

   Open questions at the time

   • Oolemmal receptor for SP-10 was not identified
   • Reliance on antibody inhibition without genetic loss-of-function limits mechanistic certainty
7. 2003 High

   Discovery that the SP-10 promoter upstream region acts as an insulator in somatic cells — blocking enhancer-promoter communication via two ACACAC motifs — explained why the gene is silent outside the germline despite possessing a functional core promoter.

   Evidence Enhancer-blocking transfection assays in COS cells; transgenic mice with CMV enhancer; site-directed mutagenesis of ACACAC motifs

   PMID:14512027

   Open questions at the time

   • The trans-acting factor mediating insulator function was unknown
   • How the insulator is inactivated in spermatids was not addressed
8. 2007 High

   Identification of TDP-43 as the insulator-binding factor that tethers the SP-10 promoter to the nuclear matrix in somatic cells, and of NF45/NF90 as spermatid-specific co-activators acting through a Pu-box element, resolved the opposing trans-acting mechanisms that enforce tissue-specific expression.

   Evidence Nuclear matrix fractionation, Gal4 tethering assay, siRNA knockdown of TDP-43, gel shift with recombinant NF45, co-transfection reporter assays in GC2 cells

   PMID:17932037 PMID:17942973

   Open questions at the time

   • In vivo NF45/NF90 activation was not confirmed — chromatin remodeling prerequisite was noted but not characterized
   • How TDP-43 tethering is released specifically in round spermatids was not determined
9. 2011 High

   Mechanistic dissection showed TDP-43 represses ACRV1 transcription in spermatocytes by promoting RNA polymerase II pausing at the promoter via its RRM1 domain in an HDAC-independent manner, establishing a kinetic model for stage-specific gene activation upon TDP-43 release.

   Evidence ChIP for TDP-43 and RNAPII on isolated germ cells; domain-deletion and GTGTGT-motif mutation analysis in reporter assays and transgenic mice

   PMID:21252238

   Open questions at the time

   • Signal or event that displaces TDP-43 at the spermatocyte-to-spermatid transition was not identified
   • Whether RNAPII pausing is a general mechanism for other spermatid-specific genes was not explored
10. 2025 Medium

    In a somatic cancer context, a ZNF280A–CUX2 transcription factor axis was shown to aberrantly activate ACRV1 transcription, and the resulting ACRV1 protein activates PI3K/AKT signaling and aerobic glycolysis, revealing an unexpected oncogenic signaling role outside the germline.

    Evidence ZNF280A knockdown, ChIP and co-IP for CUX2 at ACRV1 promoter, AKT/glycolysis inhibitor rescue, xenograft models in ovarian cancer cells

    PMID:41338461

    Open questions at the time

    • Mechanism by which ACRV1 protein activates PI3K/AKT was not defined
    • Single study in ovarian cancer — generalizability to other cancers or normal somatic tissues is unaddressed
    • Whether the germline insulator mechanism is specifically disrupted in these cancer cells was not investigated

• The oolemmal receptor for SP-10 remains unidentified, and genetic loss-of-function models (knockout) have not been reported, leaving the in vivo requirement of ACRV1 for male fertility unresolved.
• No ACRV1 knockout phenotype has been reported in any organism
• The molecular mechanism linking ACRV1 to PI3K/AKT activation in somatic cells is undefined
• Structure of the processed SP-10 peptides has not been determined